Cite
MLA Citation
LC Coates et al.. “AB0772 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved low disease activity related to psoriatic arthritis disease activity score (PASDAS).” Annals of the rheumatic diseases, vol. 76, n.d., p. 1326. http://access.bl.uk/ark:/81055/vdc_100135153256.0x000060